296 related articles for article (PubMed ID: 15241487)
1. MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol.
Domina AM; Vrana JA; Gregory MA; Hann SR; Craig RW
Oncogene; 2004 Jul; 23(31):5301-15. PubMed ID: 15241487
[TBL] [Abstract][Full Text] [Related]
2. Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2/M accumulation or protein phosphatase 1/2A inhibition.
Domina AM; Smith JH; Craig RW
J Biol Chem; 2000 Jul; 275(28):21688-94. PubMed ID: 10777489
[TBL] [Abstract][Full Text] [Related]
3. Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C.
Townsend KJ; Trusty JL; Traupman MA; Eastman A; Craig RW
Oncogene; 1998 Sep; 17(10):1223-34. PubMed ID: 9771965
[TBL] [Abstract][Full Text] [Related]
4. Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents.
Vrana JA; Cleaveland ES; Eastman A; Craig RW
Apoptosis; 2006 Aug; 11(8):1275-88. PubMed ID: 16761109
[TBL] [Abstract][Full Text] [Related]
5. Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines.
McDaid HM; Horwitz SB
Mol Pharmacol; 2001 Aug; 60(2):290-301. PubMed ID: 11455016
[TBL] [Abstract][Full Text] [Related]
6. Regulation of MCL1 through a serum response factor/Elk-1-mediated mechanism links expression of a viability-promoting member of the BCL2 family to the induction of hematopoietic cell differentiation.
Townsend KJ; Zhou P; Qian L; Bieszczad CK; Lowrey CH; Yen A; Craig RW
J Biol Chem; 1999 Jan; 274(3):1801-13. PubMed ID: 9880563
[TBL] [Abstract][Full Text] [Related]
7. N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells.
De Biasio A; Vrana JA; Zhou P; Qian L; Bieszczad CK; Braley KE; Domina AM; Weintraub SJ; Neveu JM; Lane WS; Craig RW
J Biol Chem; 2007 Aug; 282(33):23919-36. PubMed ID: 17561513
[TBL] [Abstract][Full Text] [Related]
8. Caffeine inhibits paclitaxel‑induced apoptosis in colorectal cancer cells through the upregulation of Mcl‑1 levels.
Mhaidat NM; Alzoubi KH; Al-Azzam SI; Alsaad AA
Mol Med Rep; 2014 Jan; 9(1):243-8. PubMed ID: 24173825
[TBL] [Abstract][Full Text] [Related]
9. 12-O-tetradecanoyl phorbol 13-acetate, protein kinase C (PKC) activator, protects human leukemia HL-60 cells from taxol-induced apoptosis: possible role for extracellular signal-regulated kinase.
Pae HO; Yoo JC; Choi BM; Lee EJ; Song YS; Chung HT
Immunopharmacol Immunotoxicol; 2000 Feb; 22(1):61-73. PubMed ID: 10737257
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance.
Deng X; Kornblau SM; Ruvolo PP; May WS
J Natl Cancer Inst Monogr; 2001; (28):30-7. PubMed ID: 11158204
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of protein phosphatase 2A (PP2A) prevents Mcl-1 protein dephosphorylation at the Thr-163/Ser-159 phosphodegron, dramatically reducing expression in Mcl-1-amplified lymphoma cells.
Nifoussi SK; Ratcliffe NR; Ornstein DL; Kasof G; Strack S; Craig RW
J Biol Chem; 2014 Aug; 289(32):21950-9. PubMed ID: 24939844
[TBL] [Abstract][Full Text] [Related]
12. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1.
Lee YC; Chen YJ; Huang CH; Chang LS
Apoptosis; 2017 Mar; 22(3):406-420. PubMed ID: 27757735
[TBL] [Abstract][Full Text] [Related]
13. Identification of major ERK-related phosphorylation sites in Gab1.
Lehr S; Kotzka J; Avci H; Sickmann A; Meyer HE; Herkner A; Muller-Wieland D
Biochemistry; 2004 Sep; 43(38):12133-40. PubMed ID: 15379552
[TBL] [Abstract][Full Text] [Related]
14. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
[TBL] [Abstract][Full Text] [Related]
16. Induction of BCL2 family member MCL1 as an early response to DNA damage.
Zhan Q; Bieszczad CK; Bae I; Fornace AJ; Craig RW
Oncogene; 1997 Mar; 14(9):1031-9. PubMed ID: 9070651
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of the effects of low concentrations of taxol in anaplastic thyroid cancer cells.
Pushkarev VM; Starenki DV; Saenko VA; Namba H; Kurebayashi J; Tronko MD; Yamashita S
Endocrinology; 2004 Jul; 145(7):3143-52. PubMed ID: 15044368
[TBL] [Abstract][Full Text] [Related]
18. The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells.
Seidman R; Gitelman I; Sagi O; Horwitz SB; Wolfson M
Exp Cell Res; 2001 Aug; 268(1):84-92. PubMed ID: 11461121
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
20. Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1.
Fan M; Du L; Stone AA; Gilbert KM; Chambers TC
Cancer Res; 2000 Nov; 60(22):6403-7. PubMed ID: 11103805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]